Market Closed -
Other stock markets
|
After market 03:58:00 pm | |||
116.40 EUR | -0.60% | 116.65 | +0.21% |
Jan. 15 | REDCARE PHARMACY : Berenberg reiterates its Buy rating | ZD |
Jan. 14 | Redcare Pharmacy: Europe's leading online pharmacy secures its position |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -5.47 | 0.72 | -3 | -3.9 | -0.27 | |||||
Return on Total Capital | -6.22 | 0.82 | -3.58 | -4.79 | -0.34 | |||||
Return On Equity % | -16.24 | -5.1 | -17.65 | -20.17 | -2.56 | |||||
Return on Common Equity | -16.24 | -5.1 | -17.65 | -20.17 | -2.75 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 19.64 | 22.68 | 25.16 | 27.55 | 24.48 | |||||
SG&A Margin | 24.52 | 22.11 | 28.16 | 31.48 | 24.71 | |||||
EBITDA Margin % | -3.73 | 1.32 | -1.98 | -2.82 | 0.8 | |||||
EBITA Margin % | -3.98 | 0.98 | -2.59 | -3.56 | 0.26 | |||||
EBIT Margin % | -4.86 | 0.57 | -2.98 | -3.92 | -0.21 | |||||
Income From Continuing Operations Margin % | -5.17 | -1.73 | -7 | -6.45 | -0.65 | |||||
Net Income Margin % | -5.17 | -1.73 | -7 | -6.45 | -0.67 | |||||
Net Avail. For Common Margin % | -5.17 | -1.73 | -7 | -6.45 | -0.67 | |||||
Normalized Net Income Margin | -3.81 | -0.59 | -2.57 | -3.14 | -0.5 | |||||
Levered Free Cash Flow Margin | -5.43 | -3.83 | 0.43 | -4.08 | -0.43 | |||||
Unlevered Free Cash Flow Margin | -4.76 | -3.16 | 0.94 | -3.64 | -0.15 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.8 | 2.01 | 1.61 | 1.59 | 2.05 | |||||
Fixed Assets Turnover | 61.12 | 22.07 | 13.88 | 14.71 | 20.87 | |||||
Receivables Turnover (Average Receivables) | 28.75 | 34.15 | 36.63 | 41.59 | 27.02 | |||||
Inventory Turnover (Average Inventory) | 11.26 | 10.85 | 8.92 | 8.89 | 11.54 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.53 | 3.41 | 3.49 | 2.88 | 2.23 | |||||
Quick Ratio | 2.34 | 2.12 | 2.58 | 1.89 | 1.45 | |||||
Operating Cash Flow to Current Liabilities | -0.51 | 0.24 | 0.09 | -0.24 | 0.27 | |||||
Days Sales Outstanding (Average Receivables) | 12.7 | 10.72 | 9.96 | 8.78 | 13.51 | |||||
Days Outstanding Inventory (Average Inventory) | 32.41 | 33.72 | 40.91 | 41.06 | 31.64 | |||||
Average Days Payable Outstanding | 18.18 | 19.57 | 29.2 | 30.65 | 28.92 | |||||
Cash Conversion Cycle (Average Days) | 26.93 | 24.87 | 21.67 | 19.19 | 16.23 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 64.1 | 8.99 | 54.85 | 66.24 | 44.16 | |||||
Total Debt / Total Capital | 39.06 | 8.25 | 35.42 | 39.84 | 30.63 | |||||
LT Debt/Equity | 56.5 | 7.72 | 53.3 | 64.11 | 42.57 | |||||
Long-Term Debt / Total Capital | 34.43 | 7.08 | 34.42 | 38.56 | 29.53 | |||||
Total Liabilities / Total Assets | 45.61 | 20.82 | 46.95 | 51.39 | 45.96 | |||||
EBIT / Interest Expense | -4.55 | 0.53 | -3.69 | -5.55 | -0.47 | |||||
EBITDA / Interest Expense | -3.19 | 1.47 | -1.87 | -3.42 | 2.59 | |||||
(EBITDA - Capex) / Interest Expense | -3.72 | -2.2 | -3.48 | -5.01 | 1.79 | |||||
Total Debt / EBITDA | -6.26 | 2.49 | -14.22 | -8.09 | 11.75 | |||||
Net Debt / EBITDA | -1.51 | -5.87 | 3.49 | -1.74 | 1.91 | |||||
Total Debt / (EBITDA - Capex) | -5.36 | -1.67 | -7.63 | -5.51 | 17.03 | |||||
Net Debt / (EBITDA - Capex) | -1.29 | 3.93 | 1.88 | -1.19 | 2.77 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 29.89 | 38.1 | 9.53 | 13.58 | 49.35 | |||||
Gross Profit, 1 Yr. Growth % | 38.63 | 59.19 | 21.53 | 24.36 | 32.73 | |||||
EBITDA, 1 Yr. Growth % | 29.36 | -162.21 | -264.06 | 57.46 | -142.58 | |||||
EBITA, 1 Yr. Growth % | 28.87 | -142.71 | -388.71 | 52.87 | -111 | |||||
EBIT, 1 Yr. Growth % | 23.03 | -119.54 | -669.55 | 46.45 | -91.98 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 7.92 | -53.76 | 342.34 | 4.67 | -85.05 | |||||
Net Income, 1 Yr. Growth % | 7.92 | -53.76 | 342.34 | 4.67 | -84.49 | |||||
Normalized Net Income, 1 Yr. Growth % | 27.58 | -75.49 | 379.42 | 36.86 | -76.25 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -0.49 | -57.99 | 255.68 | 4.07 | -85.51 | |||||
Accounts Receivable, 1 Yr. Growth % | 21.12 | 12.23 | -6.87 | 7.47 | 243.73 | |||||
Inventory, 1 Yr. Growth % | 30.77 | 43.31 | 18.94 | 3.19 | 36.18 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % |